Michael Bornemann, MD
Endocrinology · Honolulu, HINPI 1184622920
Payments from drug & device makers
Across 687 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Lilly USA, LLC$2K
- Sanofi-aventis U.S. LLC$1K
- AstraZeneca$1K
- Amgen$1K
- Radius Health, Inc.$951
- plus $5K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 157 | $2,615 |
| Lilly USA, LLC | 87 | $1,620 |
| Sanofi-aventis U.S. LLC | 75 | $1,402 |
| AstraZeneca(2 entities) | 61 | $1,260 |
| Amgen(2 entities) | 46 | $1,019 |
| Radius Health, Inc. | 40 | $951 |
| Boehringer Ingelheim | 31 | $799 |
| Dexcom, Inc. | 36 | $709 |
| Bayer | 31 | $627 |
| Insulet Corporation | 27 | $598 |
| Mannkind Corporation | 22 | $449 |
| Merck | 17 | $337 |
| Johnson & Johnson | 18 | $239 |
| Abbott | 12 | $205 |
| Pfizer | 5 | $148 |
| Corcept Therapeutics | 6 | $141 |
| Medtronic(2 entities) | 5 | $128 |
| Chiesi USA, Inc. | 2 | $49 |
| Neurocrine Biosciences, Inc. | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Amryt Pharma Holdings Ltd | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
How this compares
Too few endocrinology providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology in Honolulu
- David Fitz-PatrickHonolulu$26.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.